SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals announced that John Wulf, formerly director of business development for Genentech, where he was employed for 17 years, has joined Axys as vice-president of business development. Wulf will manage business development in areas of genomics and small-molecule drug development. He reports directly to Daniel Petree, CEO of the life sciences firm here. Petree said Wulf's background will be an asset to Axys as the company expands its efforts toward broad collaborations in inflammatory diseases, metabolic disorders, and oncology.
Genentech Exec Joins Axys Pharmaceuticals
Dec 18, 1998